Oregon nuclear company NuScale sued by investors over executives’ stock sales
NuScale Power Corp. faces a lawsuit from investors who allege executives misled the public about the company's financial health and project progress, inflating stock prices before selling shares for over $3.25 million. The lawsuit, filed in the U.S. District Court of Oregon, claims NuScale violated federal securities laws. Investors cite a price target cut by UBS from $10 to $6 per share in September, citing a projected $700 million negative free cash flow.
How this was made

The 30-second read
Why it matters
The filing adds legal risk, could affect financing, and may trigger regulatory reviews.
Market read
The lawsuit is a fresh, material disclosure that could depress NuScale's share price in the short term.
What to watch
Potential settlement terms and insurance coverage could mitigate downside.
Background
NuScale Power Corp., a leader in small modular nuclear reactors, faced a shareholder lawsuit alleging executive misconduct.
Market effects
May raise scrutiny on other small‑modular reactor firms and nuclear‑tech stocks.
Limited to U.S. investors; no broader regional effect.
Minimal global impact beyond the niche nuclear‑energy sector.
Counterpoint
If the lawsuit is dismissed, the stock could rebound on short‑covering.
Key entities
- companyNuScale Power Corp.
US‑listed nuclear‑technology firm.
- institutionU.S. District Court of Oregon
Venue where the lawsuit was filed.
_83269_77797.jpg&w=2048&q=75)


